Test 2 Blood Component Therapy Flashcards

1
Q

Major functions of plasma

A

Maintenance of blood volume
Suspended cellular elements - RBS, WBCs, PLTs
O2 CO2 transport
Nutrient exchange
Hormone transport (endocrine)
Waste evacuation
Temp regulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

RBC Antigena

A

At least 80 different on RBCs
ABO
- A antigens, B antigens, neither = O, both + AB
- A and B dominant over O but codominant with each other
RH
- if present Rh+
- if not Rh-
- positive dominant over negative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where are antibodies and antigens

A

Antibodies in the plasma
Antigens on the RBC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Blood type A

A

A antigen on RBC
Anti-B in plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Blood type B

A

B antigen on RBC
Anti-A in plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Blood Type AB

A

A and B antigens on RBC
No antibodies in plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Blood Type O

A

No antigens on RBC
Anti-A and Anti-B in plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Blood component therapy

A

Transfusion - admin of whole blood or components directly into blood stream
Regulated by federal government
Stringent requirements on: collection, testing, storage and distribution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Homologous blood

A

Transfusion option
Collected from random volunteers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Autologous blood

A

Transfusion option
Collected from intended recipient prior to planned procedures
Salvaged during surgery “cell saver”
Eliminates risk of alloimmunization, immune-mediated transfusion reactions and transmission of viral disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Designated (directed) blood

A

Transfusion option
Commented from donor designated by recipient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Composition of Whole Blood

A

400-500 mL/unit
RBCs
Plasma - which contains plasma proteins
Stable clotting factors
Anticoagulant/preservative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Indications of need of whole blood

A

Symptomatic anemia and major volume deciding
Massive hemorrhaging with hypotension, tachycardia, SOB, pallor, low Hgb and Hct
RARELY requires and often medically unnecessary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Admin of Whole Blood

A

Must be ABO AND Rh compatible
Rate of infusion:
Initially: a ml/kg/hr for 15 minutes
Then: 125 cc/hour to infused in 2-4 ours
As fast as tolerated in massive blood loss or shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Equipment for whole blood transfusion

A

19 gauge or larger
23 gauge for pets
Standard straight or Y-type blood infusion set with 170 micron filter
0.9% norm saline
NEVER add meds or mix with other solutions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Expected outcome for whole blood

A

Resolution of symptoms of hypovolemic shock and anemia
1 unit whole blood >
- Increase Hct by about 3%
- increase Hgb by 1 g/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Complications of whole blood transfusions

A

Hemolytic reaction
Allergic reaction
Hypothermia
Electrolyte disturbances
Citrate intoxication
Infectious disease (less likely)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Composition of PRBCs

A

250-300 mL/unit
RBCs centrifuged from whole blood
80-90% of plasma removed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Citrate-phosphate-dextrose-adenine (CRDA) PRBC

A

Shelf life 35 days
Hct 80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Additive Solution (100 ml) (AS-1, AS-3, AS-5) PRBCs

A

Increased shelf life 42 days
Decreased viscosity Hct 55-60%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Indications of need of PRBC

A

Don’t need volume expansion just increased carrying ability
Symptomatic anemia
- nutritional deficiencies
- acute/chronic blood loss
NOT for:
Volume expansion
Wound healing
General well-being

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Admin of PRBCs

A

Mush be ABO and Rh compatible Rate
Rate of infusion:
Initially: 1 mL/kg/hr for 15 minutes
Then: 125 cc/hr to infuse in 2-4 hours
Mat be subdivided into aliquots
Inures without AS may be viscous and require dilation with NS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Equipment for PRBC transfusion

A

19 gauge or larger
23 for pets
Standard straight or y-type blood infusion set with 170 micron filter
0.9% normal saline
NEVER add meds or mix with other solutions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Expected outcome of for PRBC

A

Resolution of symptoms of anemia
1 unit whole blood >
- increase Hct by ~ 3%
- increase Hgb by 1 g/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Complications of PRBC transfusions
Infectious disease Hemolytic reaction Allergic reaction Hypothermia Electrolyte disturbances Citrate intoxication (multiple rounds)
26
Leukocyte Poor RBCs Washing
Performed at time of collection Removes 80-95% of WBCs and virtually all plasma Decreased K+ level Esquires a hour for processing Must be transfused w/in 24 hours
27
Leukocyte poor RBCs freezing
Performed within 6 days of collection Can be stored for 10 years Thawing and removal of cryoprotectant eliminates virtually all plasma and 99% of WBC Require 90 minutes for processing Must Must be transfused w/in 24 hours
28
Expected outcome of leukocyte poor red blood cells
Prevention of reaction caused by infusion of WBCs and foreign proteins Remove of most leukocytes bay also decrease risk of alloimmunization and transmission of CMV
29
Complications of Leukocyte poor RBC transfusions
Hemolytic reaction Hypothermia Electrolyte disturbances Citrate intoxication Infectious disease
30
Composition of irradiated RBCs
Exposed to a measured amount of radiation Donor lymphocytes incapable of replication Performed prior to release Labeled “irradiated” Carries NO radiation risk
31
Indication of need of irradiated RBC transfusion
Hodgkin’s or non-Hodgkin’s lymphoma Acute leukemia Congenital immunodeficiency disorders Low birth weight neonates Intrauterine transfusions Bone marrow transplants
32
Expected outcome of Irradiated RBC transfusion
Prevention of GVHD
33
Complication of Irradiated RBC transfusion
Hemolytic reaction Hypothermia Electrolyte disturbances Citrate intoxication Infectious diseases
34
Composition of Platelets
200-400 mL in 4-6 pooled or single apheresis unit Removed from 4-6 units of whole bood Contain some RBCs 35-50 mL/unit
35
Pooled Platelets composition
5.5x10^10 PLT in 50-70 mL plasma per unit
36
Apheresis Platelets composition
30x10^10 PLT in 200-400 mL plasma per unit
37
Types of Platelet transductions
Random donor Single donor HLA- matched
38
Indication of need of Platelet transfusion
Thrombocytopenia (chemotherapy) Platelet dysfunction PLT < 10-20,000 or active bleeding and PLT < 50,000 S/S: petechia, gun bleeding, ecchymoses, hematuria, bloody stool NOT FOR: Immune thrombocytopenic purpura Prophylaxis with massive blood loss or CABG
39
Admin of Platelet transfusion
Do NOT refrigerate - max storage 5 days ABO testing not necessary but usually done Infusion rate: - 10 ml/min - infused within 4 hours
40
Equipment for platelet transfusions
Do NOT use RBC filter Use component set with 170-micron filter obtained from blood bank Leukocyte-poor filters also available 19 gauge or larger needle 0.9% NS
41
Expected outcome for platelet transfusions
Prevention or resolution of bleeding d/t thrombocytopenia or PLT dysfunction 1 unit of platelets > - increase count by 5,000/µL PLT count within one hour of transfusion
42
Complications of platelet transfusions
Infectious disease Allergic reactions Febrile reactions
43
Composition of Fresh Frozen Plasma (FFP)
200-250 mL/unit Plasma rich in clotting factors with platelets removed 91% water 7% proteins (clotting factors, albumin, globulins, antibodies) 2% carbohydrates Freezing within 6 hours preserves clotting factors
44
Indications of need of FFP transfusion
Demonstrated deficiency of clotting factors - DIC (Disseminated Intravascular Coagulation), liver disease, coagulopathies PT or PTT > 1.5 x normal NOT FOR: Volume expansion Nutritional supplement Prophylaxis with massive blood loss of CABG
45
Admin of FFP Transfusion
Contains no RBCS Administer ABO and Rh compatible plasma Transfuse within 24 hours of thawing Infusion rate: 200 mL/hour Slower if risk of circulatory overload
46
Equipment for FFP transfusion
Do NOT use RBC filter Use component set with 170-micron filter from blood bank 19 gauge or larger 0.9% NS NEVER add meds or diluent
47
Expected outcome for FFP transfusion
Monitor coagulation function (PT and PTT) Specific factor assays
48
Complications of FFP transfusion
Allergic reaction Febrile reaction Circulatory overload Infectious disease
49
Description of Cryoprecipitate Antihemophic Factor (AHF)
~ 30 mL Lyophilized concentrate containing Factor VIII 250 mg of fibrinogen 20-30% Factor XIII From large pools or donor plasma Heat a/o solvent-detergent treatment eliminates risk of viral transmission
50
Indications of need for Cryoprecipitate Antihemophic Factor transfusion
Factor VIII - factor VIII deficiency (Hemophilia A) - Von Willebrand’s disease - hypofibrinogenemia - factor XIII deficiency Factor IX deficiency (Hemophilia B)
51
Admin of Cryoprecipitate Antihemophic Factor transfusion
Dose is calculated based on plasma volume 8-10 badges supply 2 g of fibrinogen (Hemostatic dose) Repeat doses may be necessary to attain satisfactory serum levels Rate of infusion: ~ 1-2 mL?min Usually 4 units (60 mL) in 15 minutes
52
Equipment for Cryoprecipitate Antihemophic Factor transfusion
Blood comment admin set with 170-micron filter obtained from bank 19 gauge or larger 0.9% NS NEVER add meds or diluent other than NS
53
Expected outcomes of Cryoprecipitate Antihemophic Factor transfusion
Hemostasis d/t increased level of deficient factor Correction of factor and fibrinogen deficiencies Cessation of bleeding Lab values required to assess effectiveness
54
Complications of Cryoprecipitate Antihemophic Factor transfusion
Allergic reactions Hepatitis
55
Composition of Albumin and Plasma Protein Factor
Prepared from plasma Albumin: - 96% albumin - 4% globulins and other proteins - available as: 5% iso-oncotic or 25% solution Plasma Protein: - 83% albumin - 17% globulins - available as: 5% solution
56
Indication of need of albumin and plasma protein factor transfusion
Volume expansion - plasma exchange - shock - massive hemorrhage Acute liver failure Burns Hemolytic disease in newborn
57
Admin of albumin factor transfusion
5%: 1-10 mL/min - faster in shock but associated with hypotension 25%: 0.2-0.4 mL/min - significant increased blood volume and BP ABO NOT a factor
58
Admin for plasma protein factor transfusion
51-10 mL/min ABO NOT a factor
59
Equipment for albumin and plasma protein factor transfusion
19 gauge or larger Standard IV transfusion set May require specific filter Set and filter may be supplied with solution
60
Expected outcome for albumin and plasma protein factor transfusion
Acquire and maintain adequate BP and volume support
61
Complications of albumin and plasma protein factor transfusion
Circulatory overload Febrile reaction Compatibility NOT a factor since no ABO blood group antibodies present CANNOT transmit hepatitis or HIV infection since pasteurization process used to prepare destroys virus
62
Composition of Immune Serum Globulins (ISG)
Concentrated aqueous solution of gamma globulins containing a higher tiger of antibodies
63
Non-specific ISG
Obtained from a a large pool of random donors Used to increase game globulin levels and enhance immune response
64
Specific ISG
Prepared from donors with high antibody titers to known antigens Hepatitis B immune globulins (HBIG) Rh (D) Immune Globulin (RhIG) aka RhoGam Varicella-Zoster Immune Globulins (VZIG)
65
Indications of need of Immune Serum Globulins Transfusion
Provide passive immune protected - HBIG - following exposure to HBV - RhIG - following exposure to Rh antigens through transfusion or pregnancy to prevent antibody dev - VZIG - immuno-compromised patient exposed to chicken pox Treat hypogamma-globulinemia
66
Special considerations for Immune Serum Globulins Transfusion
Patients with a history of severe allergic reactions to plasma should NOT receive ISG Neither HIV not Hep-B is transmitted by ISG however some intravenous gamma globulins solutions have been reported to transmit Hep-C
67
Admin of Immune Serum Globulins Transfusion
Most given IM but can be IV IM injections may be painful and result in local irritation - use warm compress NEVER give IM preped IV d/t risk of anaphylaxis READ package inserts carefully Give ISG prior to or as soon after exposure as possible RhIG and VZIG MUST be admined within 72 hours of exposure for optimal effect
68
IV ISG
Admin only using a filter DO NOT admin with other meds Begin infusion within 2 hours after reconstitution
69
Expected outcome of Immune Serum Globulins Transfusion
Transient correction of gamma globulins deficiency or prevention of disease through the passive administration of antibodies
70
Composition of Granulocyte transfusions
1 unit contains: - a minimum of 1.0x10^10 granulocytes - variable amounts of lymphocytes - 30-50 mL of RBCs - 100-400 mL f plasma - 6-10 units of platelets (optional) Volume: With platelets: 200-400 mL Without platelets: 100-200 mL
71
Indications of need of Granulocyte transfusions
Acquired neutropenia - chemotherapy - radiation Congenital WBC dysfunction Serious infection unresponsive to conventional antibiotics Long term therapeutic benefits stills questionable
72
Admin of Granulocyte transfusions
1 unit daily - 1.0x10^10 granulocytes Give slowly over 1-4 hours Have short survival time Infuse ASAP (within 24 hours) To prevent reaction premedication with: - antihistamines - acetaminophen - steroids - meperidine
73
Equipment for Granulocyte transfusions
Standard blood component set with 170-micron filter from bank 19 gauge or larger 0.9% NS NEVER add meds or diluent do NOT use depth type microaggregate or leukocyte depletion filter that could trap WBCs during infusion
74
Expected outcome of Granulocyte transfusions
Improvement in or resolution of infection No increase in peripheral WBC is seen in adults but may be seen in children Improvement in clinical condition is only measurement of effectiveness
75
Complications of Granulocyte transfusions
Rash Febrile reaction * Hepatitis Increased incidence of febrile, nonhemolytic reactions with transfusion of granulocytes * - infuse slowly - observe patient closely do NOT admin Amphotericin B w/in 4 hours of granulocytes infusion d/t risk of pulmonary insufficiency
76
Acute transfusion reaction
Acute hemolytic Febrile, non-hemolytic (most common) Mild allergic Anaphylactic Circulatory overload Sepsis Transfusion related a true lung injury (TRALI)
77
Delayed transfusion reaction
Delayed hemolytic Hepatitis B Hepatitis C HIV-1 infection Iron overload GVHD Other: CMV, HTLV-I, malaria
78
General manifestations of transfusion reactions
Fever ^ 1-2 degrees C Chills Muscle aches and pains Back pain Chest pain Headache Heat at site of infusion or along vein
79
Nervous System Manifestations of Transfusion reaction
Apprehension Sense of impending doom Tingling, numbness
80
Respiratory Manifestations of Transfusion reaction
Respiratory rate - tachypnea - apnea Dyspnea Cough Wheezing Rales
81
GI Manifestations of Transfusion reaction
N/V Pain, abdominal cramping Diarrhea (may be bloody)
82
Renal Manifestations of Transfusion reaction
Changes in urine volume - oliguria/anuria - retail failure Change in urine color - dark, concentrated - shades of red, brown or amber - may indicate presence of RBCs or hemoglobin in urine
83
Cardiovascular Manifestations of Transfusion reaction
Heart rate - bradycardia - tachycardia Blood pressure - hypotension, shock - hypertension Peripheral circ - cyanosis, facial flushing - temp: cool/clammy, hot/flushed/dry Bleeding - generalized (DIC) - oozing at surgical site
84
Integumentary Manifestations of Transfusion reaction
Rashes/ hives/ swelling Itching Diaphoresis
85
Manifestations of Transfusion reaction in an unconscious patient
Weak pulse Fever Hypotension Visible hemoglobunuria Increased operative bleeding Vasomotor instability Oliguria/anuria
86
Causes of an Acute Hemolytic Transfusion Reaction
Infusion of ABO-incompatible whole blood, RBCs or components containing 10 mL or more RBCs Antibodies in the recipients plasma attach to antigens on transfused RBCs causing destruction
87
Manifestations of acute hemolytic Transfusion Reaction
Chills and fever Low back pain Flushing Tachycardia Tachypnea Hypotension Vascular collapse Hemoglobinemia Bleeding Acute renal failure Shock Cardiac arrest Death
88
Management of acute hemolytic Transfusion Reaction
STOP TRANSFUSION Treat shock if present Draw blood samples for serologic testing slowly to avoid hemolysis Send urine to specimen lab Maintain BP with IV colloid solutions Give diuretics to maintain output Insert in dwelling catheter or maintain urine output Dialysis if renal failure
89
Prevention of acute hemolytic Transfusion Reaction
Meticulously verify and document patient identification from sample collection to component transfusion
90
Cause of acute febrile non-hemolytic Transfusion Reaction
Sensitization to donor WBCs, PLTs or plasma proteins
91
Manifestations of acute febrile non-hemolytic Transfusion Reaction
Sudden chills Fever (above 1 degrees C or 2 F) Headache Flushing Anxiety Muscle pain
92
Management of acute febrile non-hemolytic Transfusion Reaction
Give antipyretics as prescribed AVOID aspirin in thrombocytopenic patients DO NOT restart transfusion
93
Prevention of acute febrile non-hemolytic Transfusion Reaction
Consider leukocyte poor blood produces
94
Cause of acute mild allergic transfusion reaction
Sensitivity to foreign plasma proteins
95
Manifestations of acute mild allergic transfusion reaction
Flushing Itching Urticaria (hives)
96
Management of acute mild allergic transfusion reaction
Give antihistamines as directed If symptoms are mind and transient - transfusion may be restarted slowly DO NOT restart transfusion if fever or pulmonary symptoms develop
97
Prevention of acute mild allergic transfusion reaction
If it has happened before treat prophylactically with antihistamines
98
Cause of acute anaphylactic transfusion reaction
Infusion of IgA proteins to IgA-deficient recipient who developed IgA antibody Kind of like shock
99
Manifestations of acute anaphylactic transfusion reaction
Anxiety Urticaria Wheezing Progression to: - cyanosis - shock - possible cardiac arrest
100
Management of acute anaphylactic transfusion reaction
Initiate CPR if indicated Have epinephrine ready for injection DO NOT restart transfusions
101
Prevention of acute anaphylactic transfusion reaction
Transfuse extensively washed RBC products from which all plasma is removed Use blood from IgA deficient donor
102
Cause of acute circulatory overload transfusion reaction
Fluid administered faster than circulation can accommodate
103
Manifestation of acute circulatory overload transfusion reaction
Cough Dyspnea Pulmonary congestion (rales) Headache Hypertension Tachycardia Distended neck veins
104
Management of acute circulatory overload transfusion reaction
Place patient upright with feet in dependent position Admin prescribed diuretics O2 and morphine Phlebotomy may be indicated
105
Prevention of acute circulatory overload transfusion reaction
Adjust transfusion volume and flow rate based on patient size and clinical status Have transfusion service divide unit into smaller aliquots for better spacing of fluid input
106
Causes of sepsis - acute transfusion reaction
Transfusion of contaminated blood components
107
Manifestations of sepsis - acute transfusion reaction
Rapid onset of chills High fever Vomitting Diarrhea Marked hypotension Shock
108
Management of sepsis - acute transfusion reaction
Obtain culture of blood and send bag with remaining blood to transfusion services for further studying Treatment septicemia as directed - antibiotics - IV fluids - vasopressors - steroids
109
Prevention of sepsis - acute transfusion reaction
Collect process store and transfuse blood products according to blood bank standards and infuse within 4 hours of starting time
110
Cause of TRALI
Transfused donor WBCs react with recipients WBCs resulting in agglutination and aggregation in lungs and pulmonary damage
111
Manifestations of TRALI
Dyspnea Fever Wheezing Chills Bronchospasm Crackles Restlessness Non-productive cough Pulmonary infiltrates Hypo or hypertension
112
Management of TRALI
STOP TRANSFUSION Maintain patent IV line Place is supine position Maintain open airway -mechanical ventilation if necessary Obtain VS and record Notify physician Admin fluids and epinephrine, steroids, diuretics per orders Admin O2 Monitor VS and output Document events
113
Manifestation of Delayed Hemolytic Transfusion Reaction
Fever Mild jaundice Decreased Hct
114
Delayed Hemolytic Transfusion Reaction
D/t destruction of transfused RBCs by alloantibodies not detected during cross match Can be as early as 3 days or as late as serval months after but using 7-14 days after
115
Treatment for Delayed Hemolytic Transfusion Reaction
Generally no acute treatment required Hemolysis may be severe enough to warrant further transfusion
116
Manifestations of Hepatitis B - Delayed Transfusion Reaction
Elevated liver enzymes (AST & ALT) Anorexia Malaise N/V Fever Dark urine Jaundice
117
Treatment for Hepatitis B - Delayed Transfusion Reaction
Usually resolves spontaneously within 4-6 weeks Chronic Carrier state can develop and result in permanent liver damage Treat symptomatically
118
Manifestations of Hepatitis C - Delayed Transfusion Reaction
Similar to Hepatitis B except symptoms are usually less severe Chronic liver disease and cirrhosis may develop
119
Treatment for Hepatitis C - Delayed Transfusion Reaction
Before anti-HCV test accounted for 90-95% of all post transfusion hepatitis Treatment symptomatically
120
Manifestations of HIV-1 (AIDS virus) Infection - Delayed Transfusion Reaction
May be asymptomatic for us to several years May develop flu like symptoms within 2-4 weeks Later symptoms: - weight loss - diarrhea - fevers - lymphadenopathy - thrush - pneumocystis pneumonia
121
Treatment for HIV-1 (AIDS virus) Infection - Delayed Transfusion Reaction
Very low risk of infection from a single blood transfusion 1:30,000 to 1:1,500,000
122
Manifestations of Iron Overload - Delayed Transfusion Reaction
Congestive heart failure Arrhythmias Impaired thyroid and gonadal function Diabetes Cirrhosis Commonly occurs in patients receiving > 100 units for chronic anemia
123
Treatment for Iron Overload - Delayed Transfusion Reaction
Treat symptomatically Deferoxamine (Desferal) - chelates and removed accumulated iron via the kidneys - may be administered IV or SubQ
124
Manifestations of GVHD (Graph vs Host Disease) - delayed transfusion reaction
Fever Rash Diarrhea Hepatitis
125
GVHD (Graph vs Host Disease) - delayed transfusion reaction
Results of replication of donor lymphocytes (graft) in the transfusion recipient (host) that attack recipients RBCS (esp in immunocompromised patients)
126
Treatment of GVHD (Graph vs Host Disease) - delayed transfusion reaction
No effective therapy available PREVENTION: Irradiated blood produced intended for immunocompromised patients May also be indicated for first degree family members’ donations
127